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Abstract Background Evidence suggests that consumers
potentially put themselves at risk when purchasing medicines
on-line. Whilst logos provided by regulators may provide
some level of reassurance there may be other indicators
which could be used by consumers to identify those websites
which may be safely used. Objectives Identify characteristics
of on-line pharmacies which are related to whether websites
are regulated or non-regulated and those characteristics
which could be used by patients to increase the likelihood of
accessing regulated sites. Setting Online pharmacies which
supply diazepam, fluoxetine and simvastatin. Methods Using
piloted search terms via Google and Yahoo search engines,
identified websites were screened for regulatory status,
adherence to regulatory standards, administrative require-
ments, clinical assessment requirements and additional
details deemed to be of relevance to a user. Characteristics of
regulated and non-regulated (defined as those with an absence
of a correctly linked regulatory logo) websites were com-
pared to identify differences which could be used to improve
patient safety. Main outcome measure Regulatory status,
adherence to regulatory standards, quality of information
provision, barriers to medicines access. Results 113 websites
sold diazepam, fluoxetine and simvastatin; were identified
within the first 100 results. Less than quarter were found to be
regulated online pharmacies. 80 websites were willing to sell
the medication without a prescription. The unregulated
internet pharmacy websites (defined as those with an absence
of a correctly linked regulatory logo) were found to adhere
more closely to the clinical criteria, were less significantly
likely to disclose a contact name and address, telephone
number of the pharmacy or demand a prescription prior to
sale (P \ 0.05, Fisher’s Exact). Conclusions The three pre-
scription-only medicines which are liable to abuse, have
potentially serious interactions and require counselling to
ensure patient safety are readily available via the internet.
When purchasing medicines via this route UK consumers
should be made aware of the importance of regulatory logos
and additionally should ensure that the seller can be mean-
ingfully contacted by the contact details provided. The pro-
vision of clinical information should not be used alone as an
indication of the seller’s provenance.
Keywords Abuse  Consumer counselling  Internet 
Online pharmacy  Regulations
Impact on practice
• Patients should be made aware of the role of regulatory
logos on on-line medicine shops.
• Provision of clinical information within websites
should not be used alone as an indicator of website
provenance.
• Medicines selling websites, which do not provide
contact details, should be avoided.
• Contact details should be checked for authenticity to
ensure website provenance.
Introduction
Online pharmacies have become increasingly popular as
they offer convenient home delivery, 24-h access, price
B. M. Alwon (&)  D. J. Wright
Medicines Management Research Group, School of Pharmacy,
University of East Anglia, Norwich NR4 7TJ, UK
e-mail: b.al-won@uea.ac.uk
G. Solomon  F. Hussain
School of Pharmacy, University of East Anglia, Norwich, UK
123
Int J Clin Pharm
DOI 10.1007/s11096-014-0056-1
Author's personal copy
comparison and enable consumers to bypass face-to-face
contact with healthcare professionals regarding personal or
sensitive conditions [1]. Two million UK citizens regularly
purchase medicines online, many of which would be
classified are requiring a prescription within the country of
purchase [2].
Prescription-only medicines (POMs) can be defined as
medicines that may ‘‘present a direct or indirect danger to
human health, even when used correctly, if used without
the supervision of a doctor’’ [3]. Any lack of personalised,
well-informed professional healthcare advice, as is the case
with most online pharmacies, is therefore a concern; this is
particularly so with medicines which are known to interact,
such as selective serotonin reuptake inhibitors, and medi-
cines which are liable to abuse such as benzodiazepines.
Moreover, should any problems arise from the ingestion of
medications purchased online; many unverified online
pharmacies have no legally recognised status, meaning that
the patient is left with no recourse [4, 5].
The rationale for governments’ requesting prescriptions
prior to supply of medicines is that it enables a healthcare
professional to select the most appropriate treatment for the
patient. Within this process they are ensuring that the
diagnosis is correct and the medicine is appropriate when
considering the patient’s medical condition and other
medicines. Additionally, they can manage those medicines
which are liable to abuse and provide requisite advice and
support to the patient. The role of the pharmacist is to
provide medicines which are from an appropriate whole-
saler, confirm the appropriateness of the prescription and to
provide additional support and guidance to the patient.
Regulated on-line pharmacies will either confirm that the
patient has a prescription or undertake the review and
assessment themselves, provide the medicine from a reli-
able source and provide advice as necessary [3, 5].
In the UK, all online pharmacies must register with the
General Pharmaceutical Council (GPhC) then they may
display a ‘registered pharmacy’ logo that is designed to
provide customers with confidence in their transactions.
The logo is verifiable and may be checked against a list of
GPhC registered pharmacies and pharmacists [2]. Similar
procedures found in the USA with the National Association
of Boards of Pharmacy (NABP) organising programme
called Verified Internet Pharmacy Practice Sites (VIPPS)
[6]. In Canada, the National Association of Pharmacy
Regulatory Authorities (NAPRA) details a set of model
internet pharmacy standards [7], which is supported by the
Canadian International Pharmacy Association (CIPA) [8].
Table 1 compares recommendations for online pharmacies
as prescribed by the UK, USA, Canadian and Australian
pharmaceutical regulatory bodies.
Research has shown that POMs can be purchased through
non-regulated on-line pharmacies when the medicine is
contraindicated [9]. Previous researchers have studied the
availability of certain medicines on online websites; one
such study was Raine et al. [9]; it investigated the avail-
ability of analgesics in the UK, finding that prescription-only
analgesics and controlled opioids (e.g. codeine and bupr-
enorphine) are readily available online, and can be pur-
chased without a valid prescription [10]. Researchers have
also found it was easy to obtain opioid medications without
a prescription and medicines such as Viagra [11, 12].
In addition to concerns regarding the safe supply of
medicines via on-line pharmacies, there is evidence of
deaths from the receipt of counterfeit medicines via unreg-
ulated sites [7, 13]. The UK Medicines and Healthcare
Products Regulatory Agency (MHRA) have warned that
there are ‘‘no guarantees of the safety, quality or efficacy of
medicines purchased in this way’’ [9]. The World Health
Organisation (WHO) reported that almost 50 % of medi-
cines sourced from online sites are counterfeit [14]. Further,
there are valid concerns over financial and personal data
security and the quality of healthcare information offered
[15]. Consequently, there are a wide variety of reasons why
patients should be directed away from unregulated sites.
Whilst the accessibility of medicines via on-line pharma-
cies has been described, the quality of regulated and non-
regulated websites has not been ascertained. Such a com-
parison may enable the identification of website characteris-
tics which can be used to inform patients purchasing
medicines to make safe decisions when selecting websites. To
provide a broad assessment of website quality we have chosen
to use medicines which are either liable to abuse (diazepam),
known to have a number of interactions (fluoxetine), or
require careful counselling and monitoring (simvastatin).
This study aims to determine the quality of approximately 100
online pharmacies and compare this between regulated and
unregulated sites. This process should enable the generation
of a set of guidelines which consumers can use when electing
to purchase medicines from online pharmacies.
Aim of the study
A detail analysis of online pharmacies will be undertaken
to assess the availability of three model medicines, the
barriers to access, adherence to regulatory standards and
the quality of information provided to identify character-
istics of on-line pharmacies which are related to whether
websites are regulated or non-regulated and those charac-
teristics which could be used by patients to increase the
likelihood of accessing regulated sites.
Ethical approval
No ethical approval was sought as there was no patient
involvement.
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Methods
This study employed an observational methodology that
assessed the selected websites anonymously. As a theo-
retical on-line exercise ethical approval was deemed not
necessary after reviewing University guidelines. The
researchers selected these commonly used medicines
(diazepam, fluoxetine and simvastatin), but did not com-
plete any purchases. Diazepam is liable to abuse and
impose risk of tolerance, dependence and withdrawal
symptoms to consumers therefore it should be used in
short-term under close monitoring [10, 16]. Fluoxetine has
significant interactions with other medicines [17, 18].
Simvastatin has a number of important counselling points
which should be relayed to the patient before use [16, 19].
Data collection form
Data was collected on regulatory (based on Table 1),
administrative and clinical criteria.
Administrative criteria assessed were:
• Payment option
• UK delivery
• Medicine availability
• Requirement for a prescription
• Questionnaire completion by patient required
• Telephone number working
Regulatory criteria assessed based on international reg-
ulatory standards were:
• Registration with relevant regulatory body
• Regulatory body logo linked to register
• Name of owner/manager/superintendent
• Address/location
Clinical assessment criteria [based on the British
National Formulary (BNF)] were:
• Information provided on cautions and contraindications
• Warnings provided on interactions
• Identifiable controls on the amount of medicine which
can be ordered
Additional information or images of interest identified
during data capture was also recorded. These included
multiple-choice health check questions, certificates of
authenticity or photographs of pharmacies and buildings
purporting to be the pharmacy, and offers of free sam-
ples of medicines. Regulatory status was identified by
the presence or absence of a correctly linked regulatory
logo.
Development of search strategy
Google.co.uk and Yahoo.co.uk were selected as they are
the most popular search engines [14]. Different search
terms were tested to identify the largest number of hits. The
search terms chosen were ‘buy [generic name] [brand
name]’ found to produce the largest number of hits.
Pilot
The spreadsheet for assessing the websites was piloted on
11 websites resulting in some minor adjustments. Some
websites were identified as sharing the same telephone
number; however, these were not excluded as they had
different URLs and site names. The pilot revealed just five
websites selling diazepam; consequently, the search terms
were reconsidered. Removal of the brand name broadened
the search, and including the word ‘pharmacy’ also yielded
more.
Process
The researcher conducted three separate searches using
‘buy fluoxetine’, ‘buy diazepam’ and ‘buy simvastatin’;
these were considered by the research team to be typical
terms for a potential buyer. Only websites which met
particular criteria were included: free access, listed within
the first 100 hits, specifically designed to distribute medi-
cines online. The first 100 hits comprised 10 pages of
search results; this was deemed by the research team
suitable as consumers are unlikely to look beyond this. All
websites, including sponsored listings, satisfying the cri-
teria were recorded in a spreadsheet. Any telephone num-
bers published were dialled to ensure that they were live.
Based on the country in which the website stated it was
located, its regulatory status was confirmed.
Table 1 A comparison of the
recommendations of different
nations for online pharmacies
Recommendation UK (22) USA (23) Canada (24) Australia (25)
Registration with relevant regulatory body 4 4 4 4
Regulatory body logo linked to register 4 4 4
Name of owner/manager/superintendent 4 4 4
Address/location 4 4 4
Telephone number 4 4
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Quality assurance
Two researchers conducted this experiment separately, and
the data collected were then independently cross-checked
to ensure that the results were consistent and satisfied all
criteria.
Data analysis
The frequencies and percentages for each variable were
calculated. Fisher’s exact test was used to compare the
adherence to criteria for regulated online pharmacies (those
registered and linked with any national regulatory body)
and non-regulated sites. Data analysis was performed using
SPSS version 18.
Results
In total, 100 websites offered UK delivery out of 113
delivered by the search engines that satisfying the criteria
identified, Fig. 1 details the findings.
It can be seen from Table 2, which summarises the
data for all 113 websites, that whilst they all had at least
one form of payment and most could deliver to the UK,
a large proportion did not state the country of origin or
the name of the owner of the pharmacy. Less than a
third of the sites provided a logo to demonstrate that
they were regulated, and a fifth of these did not link to
the regulatory body.
The adherence for the clinical criteria were compiled
and a sample of the results is shown in Table 3; they fairly
represent the full range of results derived from the 113
websites. The checking for interaction with other medica-
tion is an example of poor adherence to the clinical criteria.
The websites asking the consumers for pregnancy status or
other medical conditions were considered as examples of
high adherence. However, even with high adherence
websites; it is still adequate for patients’ safety.
Of 25 sites offering diazepam, only eight imposed a
quantity limit. For fluoxetine and simvastatin, it was pos-
sible to order 200 or more, with some websites offering a
quantity-based discount.
Table 4 provides a comparison of website criteria for the
regulated and non-regulated websites. The significant
results are that the unregulated websites are less likely to
include the name, owner, telephone number and address,
and are less likely to request a prescription before sale.
Working telephone numbers included in unregulated
websites are slightly more than that in those regulated.
Unregulated sites are more likely than regulated sites to
offer e-checks (direct electronic transfer of money from
consumer bank account) as a payment option as these do
not require the pharmacy to declare an address.
Table 5 provides a comparison of clinical criteria
between regulated and unregulated sites. Only results
Fig. 1 Flowchart illustrating
the general findings of the
searches
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where significant differences were identified are included
and these were found only for fluoxetine and simvastatin. It
can be seen that unregulated sites seem to provide more
clinical information than regulated sites.
Additional information of interest
It was noted by the researchers that screening question-
naires which included multiple-choice questions often had
the ‘right’ answer pre-selected, thereby allowing the con-
sumer to complete the questionnaire without reading it or
providing personal information. It was not possible to
determine whether pre-screening questionnaires were
scrutinised by a healthcare professional. Some sites offered
customers free introductory samples of other types of
medicine like 100 mg Viagra.
Moreover, Fig. 2 provides examples of certificates
viewed after clicking a link embedded in a regulatory logo
published on regulated online pharmacies’ websites. A
number of unregulated sites provided unverifiable photo-
graphs of the pharmacy to provide some legitimacy
(Fig. 3).
Table 2 Frequencies for adherence to quality criteria
Criteria n = number of online pharmacies (%)
Diazepam
n = 25
Fluoxetine
n = 78
Simvastatin
n = 101
All
n = 113
Payment
Debit/credit card 22 (88) 71 (91) 94 (93.1) 104 (92)
Bank transfer 9 (36) 11 (14.1) 16 (15.8) 20 (17.7)
E-checka 6 (24) 27 (34.6) 30 (29.7) 32 (28.3)
Cheque 3 (12) 12 (15.4) 14 (13.9) 14 (12.4)
Country
Not stated 12 (48) 26 (33.3) 38 (37.6) 44 (38.9)
UK 7 (28) 9 (11.5) 15 (14.9) 17 (15)
USA 1 (4) 8 (10.3) 7 (6.9) 10 (8.8)
Canada 1 (4) 22 (28.2) 22 (21.8) 22 (19.5)
Australia 0 (0) 0 (0) 1 (1) 1 (0.9)
Other 4 (16) 13 (16.7) 18 (17.8) 19 (16.8)
UK delivery available 22 (88) 65 (83.3) 92 (91.1) 100 (88.5)
Telephone number present 22 (88) 61 (78.2) 85 (84.2) 93 (82.3)
Telephone number live 18 (81.8) 53 (86.9) 76 (89.4) 82 (88.2)
Name of pharmacy 16 (64) 45 (57.7) 57 (56.4) 63 (55.8)
Address of pharmacy 10 (40) 41 (52.6) 53 (52.5) 55 (48.7)
Owner of pharmacy 5 (20) 7 (9) 14 (13.9) 14 (12.4)
Prescription required for sale 8 (32) 31 (39.7) 33 (32.7) 33 (29.2)
Faxed 2 (25) 23 (74.2) 24 (72.7) 24 (72.7)
Emailed 2 (25) 19 (61.3) 20 (60.6) 20 (60.6)
Posted 6 (75) 25 (80.6) 25 (75.8) 25 (75.8)
Health screen before sale 2 (8) 27 (34.6) 38 (37.6) 43 (38.1)
Free type 2 (100) 26 (96.3) 35 (92.1) 40 (93)
Set answers 2(100) 10 (37) 17 (44.7) 19 (44.2)
Registration logo present 6 (24) 29 (37.2) 35 (34.7) 35 (31)
General Pharmaceutical Council (GPhC) 5 (83.3) 6 (20.7) 11 (31.4) 11 (31.4)
Verified Internet Pharmacy Practice Sites (VIPPS) 1 (16.7) 1 (3.4) 1 (2.9) 1 (2.9)
Canadian International Pharmacy Association (CIPA) 0 (0) 20 (69) 21 (60) 21 (60)
Other 0 (0) 2 (6.9) 2 (5.7) 2 (5.7)
Logo is linked to regulatory body 5 (83.3) 23 (79.3) 28 (80) 28 (80)
a A directly electronic transfer of money from current bank account
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Discussion
It is evident that the three POMs under consideration from
113 websites in this study (diazepam, fluoxetine and sim-
vastatin) are obtainable with ease online and often without
a valid prescription, health professional scrutiny or adher-
ence to regulatory standards. There is also evidence of
attempts made by some unregulated online pharmacies to
legitimise their appearance by the use of registration logos
that are not linked or registered with any national regula-
tory body, pictures and unfiltered clinical information. To
improve safety of on-line purchases of medicines patients
should be encouraged to use websites which are clearly
regulated. If they are at all unsure then confirming that
contact details are real and telephone lines are live may
help. Websites which illegally use regulation logos should
be actively closed down.
Whilst the data was confirmed by duplicate data col-
lection, no medicine purchases were actually made and this
may represent a limitation, as it is therefore not possible to
know if the consumer would have been provided with any
extra clinical information about the medicine purchased,
whether the products were counterfeit or even whether
medicines would have been sold when they were clearly
clinically inappropriate. The results of this study are based
on three drugs only and therefore cannot be generalised
beyond these.
Valid prescriptions
Despite the legal requirement for an authentic prescription
in the UK [15] over two-thirds of the websites in this
study were willing to supply consumers with POMs
without a prescription. Of the remaining third of the
websites, almost three-quarters would sell based on a
faxed prescription, and approximately two-thirds with an
emailed prescription. This is also alarming, as a consumer
could fax or email the prescription to many different
pharmacies, which contravenes the definition of a valid
prescription [15].
Table 3 A sample of poor,
middle and good adherence to
criteria for diazepam, fluoxetine
and simvastatin
Criteria n = number of online
pharmacies (%)
Diazepam
n = 25
Chronic psychosis 0 (0)
Identified whether patient co-prescribed beta-blockers? 0 (0)
Identified whether patient co-prescribed fluvoxamine 2 (8)
Identified whether patient co-prescribed rifampicin 2 (8)
Identified whether patient co-prescribed clozapine 3 (12)
Asked for history of any respiratory disease 8 (32)
Restriction on quantity that could be ordered per a transaction 8 (32)
Asked for pregnancy status 9 (36)
Fluoxetine
n = 78
Identified whether patient co-prescribed antiepileptics 0 (0)
Identified whether patient co-prescribed nifedipine 0 (0)
Identified whether patient co-prescribed tamoxifen 0 (0)
Asked for history of mania 14 (17.9)
Asked for alcohol consumption 15 (19.2)
Identified whether patient co-prescribed carbamazepine 15 (19.2)
Identified whether patient co-prescribed MAOIs 36 (46.2)
Asked for diabetes mellitus 37 (47.4)
Asked for pregnancy status 44 (56.4)
Simvastatin
n = 101
Identified whether patient co-prescribed alitretinoin 0 (0)
Identified whether patient co-prescribed amlodipine 0 (0)
Identified whether patient co-prescribed dasatinib 0 (0)
Identified whether patient co-prescribed myopathy 15 (14.9)
Identified whether patient co-prescribed voriconazole 16 (15.8)
Identified whether patient co-prescribed fibrates 24 (23.8)
Identified whether patient co-prescribed ciclosporin 42 (41.6)
Identified whether patient co-prescribed coumarins 42 (41.6)
Asked for liver disease 64 (63.4)
Int J Clin Pharm
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Professional scrutiny and quantities
On some websites the consumer was requested to complete
a questionnaire; this is intended to give confidence to
consumers regarding regulatory standards. However, it is
possible to bypass the questionnaire through following the
default process (leaving the default responses in place)
without entering any patient-specific information; hence
this is a flawed process which can result in the consumer
obtaining a medicine that is contra-indicated or that inter-
acts with other medications. Furthermore, for these web-
sites, it was not possible to confirm whether the screening
process had been scrutinised by a qualified healthcare
professional. It is again possible that such sales are auto-
matically approved and questionnaires ignored; thus rais-
ing the prospect that such internet pharmacy sales are
unsafe and could compromise patient health.
The websites assessed in this study often allowed the
consumer to decide upon the quantities of the requested
medicines. Long-term non-monitored consumption is not
recommended [20]. Of the 25 sites selling diazepam, two-
thirds did not impose any such limits on quantity. Thus, it
is possible for consumers to continually self-medicate
which, with benzodiazepines, could result in, or further
contribute to, physical and psychological dependence and
tolerance [20, 21].
Fluoxetine and simvastatin were also available online in
large quantities and some offered discounts dependent on
the volume purchased. Discount online purchasing
encourages the consumer to stockpile medicines which
facilitates over use.
Consumers are also induced to place an order by certain
online pharmacies through the offer of free tablets (should
they make a purchase). This represents an additional safety
Table 4 A comparison of
adherence to quality criteria,
between regulated and non-
regulated websites
a A directly electronic transfer
of money from current bank
account
Regulated? means those
registered and linked with any
national regulatory body
Criteria n = number of online pharmacies (%) P (Fisher’s Exact)
Regulated?
n = 28
Non-regulated?
n = 85
Payment
Debit/credit card 28 (100) 76 (89.4) 0.109
Bank transfer 2 (7.1) 18 (21.2) 0.151
E-checka 2 (7.1) 30 (35.3) 0.003
Cheque 11 (39.3) 3 (3.5) \0.001
Diazepam available 5 (17.9) 20 (23.5) 0.609
Fluoxetine available 23 (82.1) 55 (64.7) 0.102
Simvastatin available 28 (100) 73 (85.9) 0.036
Country
Not stated 0 (0) 44 (51.8)
UK 10 (35.7) 7 (8.2)
USA 1 (3.6) 9 (10.6)
Canada 13 (46.4) 9 (10.6)
Australia 0 (0) 1 (1.2)
Other 4 (14.3) 15 (17.6)
UK delivery available 26 (92.9) 74 (87.1) 0.513
Telephone number present 28 (100) 65 (76.5) 0.003
Working tel. no. 24 (85.7) 58 (89.2) 0.729
Name of pharmacy 27 (96.4) 36 (42.4) \0.001
Owner of pharmacy 11 (39.3) 3 (3.5) \0.001
Address of pharmacy 28 (100) 27 (31.8) \0.001
Prescription required for sale 22 (81.5) 11 (12.9) \0.001
Faxed 15 (68.2) 9 (81.8) 0.681
Emailed 11 (50) 9 (81.8) 0.132
Posted 21 (95.5) 4 (36.4) 0.001
Health screen before sale 13 (46.4) 30 (35.3) 0.370
Free type 12 (92.3) 28 (93.3) 1.000
Set answers 5 (38.5) 14 (46.7) 0.743
Int J Clin Pharm
123
Author's personal copy
concern, as neither their active ingredients nor their dosage
are made clear to the consumer at the point of sale.
Regulatory standards and clinical criteria
The country of origin was not disclosed by over a third of
the websites studied, which has ramifications for tracing
the medicines’ sources, potentially important as unregu-
lated sites may follow lower quality assurance standards
and supply medicines to countries that are struggling to
maintain higher standards of safety and medical efficacy.
Some of the websites, although outwardly different, gave
the same addresses and photographs of headquarters to
provide confidence to consumers.
A lack of a valid or live contact telephone number
provides no recourse for consumers. It would therefore
seem appropriate for patients to test any provided tele-
phone numbers for authenticity prior to making a purchase.
This in itself may not, however, provide any further reas-
surance as fraudulent suppliers could populate the line with
an automated answering service. The fact that some web-
sites shared the same telephone number indicates that
perhaps a single company was operating under several
different names to capture a greater market share.
Interestingly, the non-regulated sites appeared to try to
satisfy the clinical criteria, often more than the regulated
ones. Although surprising, regulated online pharmacies
tend to assume that the necessary criteria have been satis-
fied by the POM prescriber, whereas the non-regulated
ones (in particular those not requiring a prescription) are
more likely to offer safety information, listing cautions and
side-effects. This approach may be utilised to provide the
unwary consumer with greater confidence in the prove-
nance of the site. Unfortunately, such information tends not
to be prominent, presented in a font which is smaller than
the rest of the text on the page and therefore is difficult to
read. A lay consumer may therefore proceed with a pur-
chase without sufficient clinical knowledge. Future work
could focus on this information, in terms of ease of access
and readability for the lay person.
This study has confirmed many findings documented in
the literature, but it has also clarified how easily medicines
(including POMs) may be obtained online with or without
prescription. It has confirmed that many websites are
reluctant to reveal their real-world location, which means
that the consumer cannot be assured of the regulatory
framework under which the pharmacy is operating. POMs
are readily available online for UK consumers, whether or
not they hold a valid prescription. Raine et al. [9] showed
that controlled opioids can easily be bought online, and this
study shows that medicines with other important clinical
concerns can also be purchased with little difficulty or
Table 5 A comparison of
adherence to clinical criteria,
between regulated and non-
regulated websites
a A site’s regulation status was
determined via the presence/
absence of a correctly linked
regulatory logo
Criteria n = number of online pharmacies (%) P (Fisher’s Exact)
Regulateda Non-regulateda
n = 28 n = 73
Simvastatin
Prescribed boceprevir 3 (10.7) 0 (0) 0.020
Prescribed ciclosporin 7 (25) 35 (47.9) 0.044
Prescribed coumarins 7 (25) 35 (47.9) 0.044
Prescribed diltiazem 0 (0) 25 (34.2) \0.001
Prescribed erythromycin 6 (21.4) 33 (45.2) 0.039
Prescribed fluconazole 0 (0) 18 (24.7) 0.003
Consumes grapefruit juice 3 (10.7) 34 (46.6) 0.001
Prescribed indinavir 0 (0) 15 (20.5) 0.010
Prescribed lopinavir 0 (0) 14 (19.2) 0.010
Prescribed rifampicin 0 (0) 11 (15.1) 0.032
Prescribed ritonavir 3 (10.7) 27 (37) 0.014
Prescribed telaprevir 3 (10.7) 0 (0) 0.020
Prescribed verapamil 1 (3.6) 29 (39.7) \0.001
Prescribed voriconazole 0 (0) 16 (21.9) 0.005
n = 23 n = 55
Fluoxetine
Prescribed clopidogrel 5 (21.7) 0 (0) 0.002
Prescribed duloxetine 3 (13) 0 (0) 0.023
Prescribed MAOIs 6 (26.1) 30 (54.5) 0.026
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scrutiny. It also found that unsuitably large quantities of
medicines (including POMs) can be ordered online with
unverified patient questionnaires representing no obstacle
to access. This concurs with the findings of Gallagher et al.
[11], who investigated online sales of sildenafil; they too
were unable to verify whether online questionnaires were
scrutinised by healthcare professionals.
This study represents a contribution to the literature, as
the criteria for screening these 113 websites, is based on
the standards of well-recognised international regulatory
bodies which enabled the current study to distinguish
between unregulated and regulated websites. This study, as
did Raine et al. [9] and Gallagher et al. [11], has high-
lighted certain safety issues. The availability of diazepam,
fluoxetine and simvastatin without prescription or adequate
professional oversight represents a threat to the health and
safety of uninformed consumers.
Recommendations for regulators and policymakers
Patient education regarding internet pharmacies as a whole
should be targeted, emphasising the dangers of bypassing
doctors or pharmacists; this has been highlighted and rec-
ommended in previous research [14, 17, 18, 22, 23]. This
study was intended to rectify this health concern through
Fig. 2 Certificates displayed on certain websites when clicking on
their ‘regulatory’ logos
Fig. 3 Photos shown on certain websites to illustrate their location
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presenting a set of guidelines for UK consumers to facili-
tate safe online purchasing. This set of guidelines would
ideally take the form of a checklist of website features,
which the consumer could use to assess an online phar-
macy (see Table 5, ‘regulated’ column). Furthermore, it
has emphasised the importance to consumers of using sites
bearing the GPhC Internet Pharmacy logo which, when
clicked, shows proof of genuine registration. The aware-
ness of the general public of the provenance provided by
this logo is, however, unknown.
While the checklist should greatly assist consumers in
purchasing medications with confidence online, it is also
important for healthcare professionals to become more
proactive and offer practical advice to patients. GPs and
pharmacists should advise their patients not to purchase
medicines from unregulated sites, not to be induced by
discounts, and not to visit any site that sells POMs without
a prescription. Such a checklist should be made available in
pharmacies and GP surgeries, and the general public should
be made aware of the GPhC register and its logo.
Conclusions
UK consumers can easily purchase diazepam, fluoxetine and
simvastatin from online pharmacies, even without a pre-
scription; these can be found through popular internet search
engines. These medicines, which should not be consumed
without proper supervision, are thus easy to access, despite
having particular clinical implications. Furthermore, they are
widely available from unregulated online pharmacies, which
represent a particular health risk. Accredited and regulated
pharmacies offer certain advantages to consumers, princi-
pally related to buying with confidence, but unregulated
online pharmacies represent a danger to patients who, for
various reasons, seek to manage their own medication. To
address this, a checklist of guidelines, in plain language,
should be compiled to aid UK consumers in making safe
online purchases from web-based pharmacies; such a
checklist could be derived from the findings of this study.
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